STOP! Every protein-coding RNA needs a termination codon or translation will run right on through the poly-adenine tail, producing a run of superfluous lysines (encoded by AAA). Such defective proteins could build up in the cell, potentially leading to neurodegeneration, according to Claudio Joazeiro of The Scripps Research Institute in La Jolla, California. Fortunately, there is a system in place that identifies nonstop proteins on their way out of the ribosome and tags them for destruction. Researchers have a good handle on how bacteria deal with nonstop proteins, but to this day do not understand how eukaryotes do it. In the September 12 Nature online, Joazeiro and first author Mario Bengtson report that a homolog of the mouse ubiquitin ligase listerin forms the heart of this policing system in yeast, suggesting that the ligase might be the ticket for run-on proteins in mice and humans as well. Curiously, listerin-mutant mice have symptoms resembling motor neuron disease, and these results might just explain why.

In an ARF interview, Joazeiro suggested the protein might also be involved in human neurodegenerative disease. Other mRNA-wrangling proteins, including TDP-43 and FUS, are relevant to neurodegeneration (e.g., see ARF related news story on Kwiatkowski et al., 2009 and Vance et al., 2009), though it is not clear if any of them interact with listerin. Listerin brings up no hits in AlzGene or other neurodegenerative gene association databases.

The listerin story began with a large-scale screen of mutant mice run by the Novartis Institute for Biomedical Research. Laboratory technicians noticed that some of the animals developed paralysis as they aged. Steve Kay and others at Scripps, including Joazeiro, analyzed these animals, which they dubbed “lister” for their listing gait (Chu et al., 2009). (Now, dear reader, you can finally stop thinking “mouthwash?”) The animals showed signs of neurodegeneration that reminded the researchers of animal models for amyotrophic lateral sclerosis, with soluble, hyperphosphorylated tau in the brain and vacuolated mitochondria in the spinal cord. The mutation mapped to a gene for a ubiquitin ligase, christened listerin.

Since then, Joazeiro has studied listerin function. Because the gene is conserved throughout eukaryotes, he and Bengtson decided to study its yeast homolog, Ltn1. Previous work in yeast suggested that Ltn1 was involved in nonstop protein metabolism (Wilson et al., 2007).

The Scripps scientists expressed two gene constructs in yeast: one a green fluorescent protein (GFP) labeled with both Flag and HIS motifs, and the other the same sequence sans the stop codon. The nonstop GFP chimera co-immunoprecipitated with Ltn1 at a higher level than the normal, stop-containing reporter, suggesting Ltn1 and the runaway protein physically interact. The scientists also found that if they knocked out Ltn1, the nonstop protein was expressed at higher levels.

Since Ltn1 shares sequences with other genes that encode ubiquitin ligases, the researchers hypothesized that Ltn1 ubiquitinated nonstop proteins. When they examined their GFP reporters, they found that the nonstop version, but not the normal one, was ubiquitinated. This was true in wild-type cells; in Ltn1-deficient cells, ubiquitination of the nonstop protein was reduced. Therefore, the researchers concluded that Ltn1 is essential for full ubiquitination and degradation of defective, unending proteins.

But how does Ltn1 identify run-on proteins? Previous research suggested that the extra lysines, coded by the mRNA’s normally untranslated poly(A) tail, give those offenders away (Ito-Harashima et al., 2007). To test this, Bengtson created a GFP-Flag-HIS3 gene with 12 consecutive lysine codons just before the stop codon. If the lysines were the Ltn1 signal, then this protein should be degraded like a nonstop protein. Sure enough, the cell ubiquitinated and broke down the extra-lysine version, but only if Ltn1 was present.

Other scientists have found that electrostatic interactions between the nascent protein and the ribosome can arrest translation (Lu and Deutsch, 2008). Lysines are positively charged; hence, Joazeiro and Bengtson hypothesized that nonstop proteins with a string of lysines might get stuck in the ribosome.

To look at that, the researchers fractionated cells and used a sucrose gradient to separate components by density. Normally, the few nonstop proteins that escape degradation float in the top, lightest layer. But in Ltn1-deficient cells, the nonstop proteins came down with the ribosomes. Ltn1 co-immunoprecipitated with the ribosomal protein Rpl3, suggesting that Ltn1 spends at least some of its time attached to ribosomes as well. These results, the authors write, suggest that Ltn1 associates with the ribosome and ubiquitinates nonstop proteins as they are synthesized. Without Ltn1, these defective proteins never manage to exit the ribosome. How Ltn1 finds the nonstop proteins is unclear; the authors hypothesize that lysine stretches might alter the ribosomal structure, opening up an Ltn1 binding site.

To understand how Ltn1 affect yeast’s ability to survive, Bengtson and Joazeiro treated cells with an antibiotic that speeds up how fast ribosomes read through stop codons. Ltn1 knockouts struggled to survive—a struggle, Joazeiro suggested, that might also occur in aging neurons.

“Defects in protein quality control are a hallmark of neurodegeneration,” Joazeiro noted. He suspects listerin may be involved in human neurodegenerative diseases. Which one is uncertain. The lister mice’s motor symptoms suggest ALS, though their generalized gliosis and hyperphosphorylated tau could imply Alzheimer’s.

Ambro van Hoof, who also studies nonstop protein degradation at the University of Texas Health Sciences Center in Houston, called the paper “exciting,” but noted that the connection between listerin and human disease remains unproven. In an e-mail to ARF, Joazeiro wrote: “Time and more research on listerin will clarify its involvement in human neurodegenerative disease.”—Amber Dance


  1. This is a fascinating and elegant study that elucidates a key mechanism controlling the translation (or halt thereof) of proteins whose mRNAs lack a stop codon. The core findings of the paper are nicely summarized on the site. The potentially exciting thing about this mechanism is a novel explanation for a rather fundamental issue in protein quality control, and a potential piece of the puzzle in "proteostasis" in neurodegenerative disorders. The mechanistic conservation of listern in mammals and Ltn1 in yeast is of interest.

    From a disease biology perspective, it will be important to determine whether listerin/Ltn1 mechanisms are impaired or lost with the large variety of age-related neurodegenerations. Alternatively, perhaps augmentation of listerin/Ltn1 could be exploited to improve protein synthetic quality control during periods of stress or aging.

Make a Comment

To make a comment you must login or register.


News Citations

  1. New Gene for ALS: RNA Regulation May Be Common Culprit

Paper Citations

  1. . Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009 Feb 27;323(5918):1205-8. PubMed.
  2. . Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009 Feb 27;323(5918):1208-11. PubMed.
  3. . A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration. Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2097-103. PubMed.
  4. . A genomic screen in yeast reveals novel aspects of nonstop mRNA metabolism. Genetics. 2007 Oct;177(2):773-84. PubMed.
  5. . Translation of the poly(A) tail plays crucial roles in nonstop mRNA surveillance via translation repression and protein destabilization by proteasome in yeast. Genes Dev. 2007 Mar 1;21(5):519-24. PubMed.
  6. . Electrostatics in the ribosomal tunnel modulate chain elongation rates. J Mol Biol. 2008 Dec 5;384(1):73-86. PubMed.

External Citations

  1. AlzGene

Further Reading


  1. . Protein quality control mechanisms and neurodegenerative disorders: Checks, balances and deadlocks. Neurosci Res. 2010 Nov;68(3):159-66. PubMed.
  2. . miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13111-6. PubMed.
  3. . Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis. 2010 Nov;15(11):1292-311. PubMed.
  4. . Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications. Int J Hyperthermia. 2009 Dec;25(8):647-54. PubMed.
  5. . Quality control against misfolded proteins in the cytosol: a network for cell survival. J Biochem. 2009 Nov;146(5):609-16. PubMed.
  6. . Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins. J Biochem. 2009 Dec;146(6):751-6. PubMed.

Primary Papers

  1. . Role of a ribosome-associated E3 ubiquitin ligase in protein quality control. Nature. 2010 Sep 12; PubMed.